Checkerspot and Huvepharma Develop Algal Oil Simulating Human Milk Fat for Infant Formula
Checkerspot, a biotechnology firm focused on renewable oils and fats, has entered into a partnership with Huvepharma, a global leader in fermentation technology, to scale production of a novel nutritional oil derived from microalgae. This high sn-2 palmitate algal oil is designed as a direct alternative to palm oil, particularly for use in infant formula, where it mimics the triglyceride structures found in human milk fat. The collaboration follows successful …
Checkerspot Develops “World’s First” High-Oleic Palm Oil Alternative Made With Microalgae Fermentation
California-based biotech company Checkerspot has announced the development of what it claims is the first ever high-oleic palm oil alternative produced entirely through microalgae fermentation. As explained in a study published this month in the journal Fermentation, Checkerspot took the microalga Prototheca moriformis and used classical strain improvement techniques to enhance oil yield and composition. The resulting oil closely matches the fatty acid profile of conventional high-oleic palm oil, containing …
Checkerspot and AAK to Produce Novel, Climate Change-Resistent Oils from Microalgae & Precision Fermentation
California’s Checkerspot and the Swedish company AAK have announced a partnership to develop, scale, and commercially produce novel algae oils for meat alternatives, plant-based food, and personal care products. Checkerspot makes renewable oils using microalgae and precision fermentation for materials and food, and AKK specializes in value-adding vegetable oils for food, confectionery, pharmaceuticals, and cosmetics. With this initiative, both companies aim to provide a sustainable alternative source of structuring fats …
Checkerspot Unveils “Breakthrough” for Baby Formula: Human Milk Fat Analog Made Using Microalgae Fermentation
California’s Checkerspot, a biotechnology firm that produces renewable oils by fermentation of microalgae, announces the development and large-scale production of fat analog that the company claims mimics the human milk fat known as OPO (Oleic-Palmitic-Oleic or sn-2 palmitate). According to the company, this “breakthrough” achievement will revolutionize infant nutrition with essential lipids that contribute to better digestion and nutrient absorption and potentially offer long-term health benefits for infants. Making a human milk …